A new study released by the Pharmaceutical Care Management Association found that coupon programs for brand-name drugs could increase costs for employers, unions and state governments by $32 billion over the course of a decade. "People get lured to high-priced drugs for no reason," with the use of the branded co-pay cards, said PCMA President and CEO Mark Merritt.

PCMA Press Release: Brand Drug "Copay Coupons" Raise Health Costs for Employers, Unions, and State Governments by $32 Billion

New Research: How Copay Coupons Could Raise Prescription Drug Costs By $32 Billion Over the Next Decade

Related Summaries